Peritoneal metastasis (PM) is often regarded as a less frequent pattern of spread; however,
collectively across all spectra of primary tumors, the consequences of PM impact a large …

Near‐infrared (NIR) fluorescence imaging is gaining clinical acceptance over the last years
and has been used for detection of lymph nodes, several tumor types, vital structures and …

Metastatic peritoneal carcinoma (mPC) is a deadly disease without effective treatment. To
improve treatment of this disease, a recently developed hyperthermic intraperitoneal …

Colorectal cancer (CRC) is the third most common cancer and the fourth most common
cause of cancer-related death worldwide. Besides the lymphatic and haematogenous routes …

Objectives The therapeutic efficacy of cytoreductive surgery (CRS) plus hyperthermic
intraperitoneal chemotherapy (HIPEC) for patients with peritoneal carcinomatosis (PC) from …

Metastatic disease occurs in half of people with colorectal cancer (CRC). Metastasis spread
through hematogenous or lymphangitic routes and may occur in lymph nodes, liver, lung …

The presence of peritoneal metastases (PM) in patients with colorectal cancer (CRC) is
associated with an extremely poor prognosis. The diagnosis of PM is challenging, resulting …

Background Patients with peritoneal metastases from colorectal cancer have a poor
prognosis. If the intraperitoneal tumour load is limited, patients may be eligible for …

Background and Objectives The aim of this study was to evaluate a new fluorescently
labeled chimeric anti‐CEA antibody for improved detection and resection of colon cancer …

Background Peritoneal metastases from colorectal cancer (CRCPM) are related to poor
prognosis. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy …